terazosin has been researched along with Blood Poisoning in 1 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X | 1 |
Zhao, C | 1 |
Li, X | 2 |
Wang, T | 1 |
Li, Y | 1 |
Cao, C | 1 |
Ding, Y | 1 |
Dong, M | 1 |
Finci, L | 1 |
Wang, JH | 1 |
Liu, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Assessing Target Engagement of Terazosin in Healthy Adults[NCT04551040] | Phase 1 | 18 participants (Anticipated) | Interventional | 2021-03-26 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for terazosin and Blood Poisoning
Article | Year |
---|---|
Terazosin activates Pgk1 and Hsp90 to promote stress resistance.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Cells, Cultured; Cytokines; HSP90 Heat- | 2015 |